| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 10, 2025 | Feb 10, 2025 | Sionna Therapeutics, Inc. | 10% Owner | Buy | 95.0 | +60,000 | 8.02% | ✗ | $1.1M |
| Feb 26, 2024 | Feb 28, 2024 | Dyne Therapeutics, Inc. | 10% Owner | Sell | 30.0 | -807,838 | -3.86% | ✓ | $19.6M |
| Feb 21, 2024 | Feb 23, 2024 | Dyne Therapeutics, Inc. | 10% Owner | Sell | 25.0 | -500,789 | -5.35% | ✓ | $11.3M |
| Feb 15, 2024 | Feb 20, 2024 | Dyne Therapeutics, Inc. | 10% Owner | Sell | 25.0 | -510,152 | -6.96% | ✓ | $11.9M |
| Feb 8, 2024 | Feb 9, 2024 | Xilio Therapeutics, Inc. | 10% Owner | Sell | 52.5 | -1,000 | -0.04% | ✗ | $640 |
| Jan 11, 2024 | Jan 16, 2024 | Xilio Therapeutics, Inc. | 10% Owner | Sell | 52.5 | -4,235 | -0.15% | ✗ | $3.6K |
| Dec 12, 2022 | Dec 14, 2022 | Dyne Therapeutics, Inc. | 10% Owner | Buy | 100.0 | +934,581 | 10.46% | ✗ | $10M |
| Jun 17, 2022 | Jun 22, 2022 | Day One Biopharmaceuticals, Inc. | 10% Owner | Buy | 97.5 | +766,667 | 9.33% | ✗ | $11.5M |
| Mar 30, 2021 | Dec 14, 2021 | ImageneBio, Inc. | 10% Owner | Buy | 92.5 | +98,722 | 4.89% | ✗ | $1.6M |
| Jun 1, 2021 | Jun 2, 2021 | Day One Biopharmaceuticals, Inc. | 10% Owner | Buy | 100.0 | +500,000 | 100.00% | ✗ | $8M |
| Jun 24, 2019 | Jun 25, 2019 | Akero Therapeutics, Inc. | 10% Owner | Buy | 100.0 | +270,000 | 114.85% | ✗ | $4.3M |